Temozolomide [clinicaltrials_resource:d9bc39935b380b6a75d3e7b73fa0bf81]
intervention [clinicaltrials_vocabulary:intervention]
Temozolomide [clinicaltrials_resource:d9bc39935b380b6a75d3e7b73fa0bf81]
Bio2RDF identifier
d9bc39935b380b6a75d3e7b73fa0bf81
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d9bc39935b380b6a75d3e7b73fa0bf81
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Priming, Group 2 only, 100 mg/ ...... ms) 200 mg/m2/day temozolomide
intervention name [clinicaltrials_vocabulary:intervention-name]
Temozolomide
other name [clinicaltrials_vocabulary:other-name]
Temodar, Temodal
identifier
clinicaltrials_resource:d9bc39935b380b6a75d3e7b73fa0bf81
title
Temozolomide
@en
type
label
Temozolomide [clinicaltrials_resource:d9bc39935b380b6a75d3e7b73fa0bf81]
@en